An 85-year-old woman with type 2 diabetes who was treated for bullous pemphigoid with steroids for 2 months presented with a fever for 3 days before hospitalization. Following diagnostic investigations, bacterial pneumonia and ketoacidosis were diagnosed. Steroid treatment was discontinued, and treatment with continuous intravenous insulin infusion and intravenous antibiotics was initiated. However,
Strongyloides stercoralis was isolated from a sputum sample on the first day after admission.
S. stercoralis hyperinfection was diagnosed, and treatment with ivermectin was initiated. During the same period, her consciousness levels and respiratory status worsened because of the development of bacterial meningitis and non-cardiogenic pulmonary edema. Treatment was therefore changed to broad-spectrum antibiotics and noninvasive positive pressure ventilation. The patient was positive for
HTLV-1 antibodies, which were evaluated after hospitalization. After 2 weeks of ivermectin treatment,
S. stercoralis was no longer detectable in the sputum or stool samples. Following hospitalization for approximately 60 days, the patient's consciousness levels and respiratory status recovered. We believe the present case is of particular interest because of its rarity and the provision of valuable clinical information related to the successful treatment of an
HTLV-1 carrier and type 2 diabetic patient with
S. stercoralis hyperinfection, ketoacidosis, bacterial meningitis, and non-cardiogenic pulmonary edema.
View full abstract